HIGHLIGHTS
- who: Sergei A. Kozlovskiy et al. from the Vladivostok, Russia have published the article: Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells, in the Journal: Toxins 2023, 47 of 30/Nov/2022
- what: The aim of this work is to study the anti-inflammatory activity of compounds, U-286 and U-548, on RAW 264.7 macrophage cells. It has been shown that these antagonists can significantly inhibit the activity of these receptors, reduce their expression level and can be used to treat concomitant diseases associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.